Kwo, P. Y. Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”. Korean Association for the Study of the Liver.
Chicago Style (17th ed.) CitationKwo, Paul Y. Metformin and Statins and Their Role in Reducing Hepatocellular Carcinoma Risk: Randomized Trials Are Needed: Editorial on “Metformin and Statins Reduce Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Failed Antiviral Therapy”. Korean Association for the Study of the Liver.
MLA (9th ed.) CitationKwo, Paul Y. Metformin and Statins and Their Role in Reducing Hepatocellular Carcinoma Risk: Randomized Trials Are Needed: Editorial on “Metformin and Statins Reduce Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Failed Antiviral Therapy”. Korean Association for the Study of the Liver.